Certified Diplomat of the American Board of Urology
Fellow of the American College of Surgeons
Dr. Elliot Lander, a Board Certified Urologist, is Co-Founder and Co-Medical Director California Stem Cell Treatment Center and the Cell Surgical Network.
Elliot B. Lander, M.D. F.A.C.S. is a Board-Certified Surgeon. He was born in Los Angeles, California. He graduated Magna Cum Laude and Phi Beta Kappa from Occidental College with Distinction in Biochemistry. He attended medical school at the University of California, Irvine. For six years after medical school, Dr. Lander studied General Surgery and then Urologic Surgery at the University of California, Irvine. He was a Clinical Assistant Professor of Urology at the same UC Irvine while in practice in Orange County for five years. During that time he was active in teaching residents and doing research.
Dr. Lander has been elected as a Fellow of the American College of Surgeons. He has served as Chief of Urology at Eisenhower Medical Center and Chief of Surgery at John F. Kennedy Hospital. Dr. Lander has been on staff at Eisenhower Medical Center for twenty years. He is also an Expert Reviewer in Urology for the California Medical Board. Dr. Lander is also doing clinical research on liposome encapsulated agents for the treatment of interstitial cystitis and is founder of Nanologix Research Inc. Additional areas of special focus also include focal treatment of prostate cancer and regenerative urology with emphasis on Peyronies Disease and erectile dysfunction. Also, one area of very special interest includes the study of the use of stem cells in developing cancer vaccines.
Dr. Lander is currently involved in cutting edge translational stem cell treatment research at the California Stem Cell Treatment Center based in Rancho mirage and Beverly Hills. Dr. Lander is also co-founder of Cells On Ice® which is a cryobanking stem cell technology company. He is a founding member of the International Cell Surgical Society, a nonprofit organization dedicated to research and education regarding the medical use of adult stem cells. Dr. Lander and his team of multispecialty experts were instrumental in bringing fat derived stem cell technology to the United States in 2010 and have pioneered several new techniques in regenerative medicine. Dr. Lander is co-founder of Cell Surgical Network, an international research network dedicated to developing cell surgical techniques studying the clinical applications of adipose derived stem cells and growth factors. Research affiliate physicians trained by the Cell Surgical Network team can be found in many U.S. cities and all around the world. The Cell Surgical Network organization oversees an online regenerative medicine database to track clinical outcomes and adverse events from stem cell treatment centers all over the globe. Dr. Lander is co-author of The Stem Cell Revolution, a popular book on regenerative medicine.
CURRICULUM VITAE | ELLIOT B. LANDER, MD, FACS
Certified Diplomate of the American Board of Urology
Fellow of the American College of Surgeons
Co-Medical Director the California Stem Cell Treatment Center®
Co-Founder and Co-Medical Director of Cell Surgical Network®
Co-Founder of Cells On Ice® Inc.
Co-Founder of Nanologix Research Inc.
1978-1982 Bachelor’s Degree, Occidental College, Los Angeles, California
1982-1986 Medical Doctor, University of California, Irvine
1986-1988 General Surgery Resident, U.C. Irvine Medical Center
1988-1992 Urology Resident, U.C Irvine Medical Center
1992-1997 Partner Physician Kaiser Permanente Medical Group, Assistant Clinical Professor of Urology, UC Irvine College of Medicine.
Co-Founder and Co-Medical Director of California Stem Cell Treatment Center
Co-Founder and Co-Medical Director of Cell Surgical Network International Research Organization
Co-Founder of Cells On Ice Inc.
Private Solo Practice of Lander Regenerative Urology – specializing in men’s health and wellness
Member of Scientific Advisory and executive board for StemImmune Corporation, San Diego, California
Founder and Scientific Advisor for Nanologix Research Inc.
AREAS OF SPECIAL EMPHASIS
Adult Stem Cell Treatment and translational research for Degenerative Diseases
Bio-Identical Hormone Replacement
Interstitial Cystitis and Peyronies Disease
CURRENT STAFF PRIVILEGES
Eisenhower Memorial Hospital, Rancho Mirage, California
Honorary Faculty American Board of Interventional Pain Physicians -Regenerative Medicine Competency Examination 2016
American Urologic Association
Fellow of the American Board of Urology
Fellow of the American College of Surgeons
Past Chief of Urology at Eisenhower Medical Center, Rancho Mirage, California
Past Chief of Surgery at John F. Kennedy Hospital, Indio, California
Dr. Lander has done special training to certify in Laser Vaginal Rejuvenation and cosmetic genital reconstruction as well as having performed over 4000 pelvic floor reconstruction procedures.
Founding Board member emeritus “BRIDGE FOR PELVIC PAIN.” A non-profit organization dedicated to advocacy, education and resources for patients with chronic pelvic pain. 2014-2017
International Cell Surgical Society- Board member 2014-current
AWARDS AND HONORS
- J. Gordon Hatfield Award in 1986. One award per year at U.C. Irvine for senior student demonstrating excellence in surgery.
- Graduated Magna Cum Laude from Occidental College with distinction in Biochemistry for honors thesis, 1982.
- Phi Beta Kappa in 1982.
- Carnation Honor Award (second highest academic merit award at Occidental college) 1978,1979,1980,1981.
- Statewide NASA Youth Science Congress award for Basic Science Research, 1978.
- National Science Foundation-Committee for Advanced Science Training Undergraduate Research Grant, 1979.
- Palm Springs Best Doctors: Dr. Elliot Lander has been named as one of the five “Top Docs” in Palm Springs for 2016. The article is featured in the July 2016 issue of Palm Springs Life magazine. Dr. Lander was also featured in Palm Springs Life magazine in 2011 as one of the top 5 of 77 of the Deserts best doctors
- Western Section American urologic Association Historical Essay Contest 4th Place- 2014
Principal Investigator: Additive Effects of Combination Therapy on Erectile Function with Tadalafil and Neo40, a Nitric Oxide Dietary Supplement.” Sponsor: NeoGenesis Labs. Houston, Texas. 2016
Principal Investigator: “Oncolytic Virus Combined with Autologous Stem Cells for Advanced Malignancy.” Sponsor: StemImmune. San Diego California. 2016
BASIC SCIENCE/CLINICAL RESEARCH PROJECTS
JUNE 1984-DECEMBER 1984
Basic science Research at University of California, Irvine Renal Transplantation Laboratory, Dr. Charles Hewitt. Studied the effects of Uremia in Rat model.
Pharmacology Research, UCLA Medical School. Studied the effects of Beta Blockers on Vascular Resistance.
Clinical Research at Cedars Sinai Medical Center (Department of Cardiac Rehabilitation) Los Angeles. Studied Myocardial Infarction and Subsequent Organic Brain Syndrome.
Organic Chemistry Research at Occidental College, Los Angeles, Ca (under Dr. Frank DeHahn, PhD). Studied Friedel-Crafts Reaction.
Medical Director and Principal Investigator of Cell Surgical Network for the IRB approved investigational study of stromal Vascular Fraction.
Co-author of “The Stem Cell Revolution.” By Mark Berman MD and Elliot Lander MD. 2015 Authorhouse Company
Authored “Forward” in “Desmystifying Stem Cells- A Real Life Approach.” By Bohdan Olesnicky MD and Naota Hashimoto DC.
- Berman S,Uhlendorf TL, Mills DK, Lander EB, Berman MH, Cohen RW. Validation of Acoustic Wave Induced Traumatic Brain Injury in Rats. Brain Sci. 2017 Jun 2;7 (6).
- Berman M, Lander E. A Prospective Study of Adipose Derived Stromal Vascular Fraction Using a Specialized Surgical Processing system. The American Journal Cosmetic Surgery. Feb 2017 (1-14).
- Lander EB, Berman MH, See J. Stromal Vascular Fraction Cells: Applications in Chronic Pain. Techniques in Regional Anesthesia and Pain Management. 19 (2015) 10-13.
- Lander EB, Berman MH, See J. Stromal Vascular Fraction Combined with Shock Wave for the Treatment of Peyronie’s Disease. Reconstr. Surg. Glob Open 2016;4:e631; doi: 10.1097 GOX.0000000000000622; Published online 2 March 2016.
- Lander EB, See JR. Intravesical instillation of pentosan polysulfate encapsulated in a liposome nanocarrier for interstitial cystitis. Am J. Clin. Exp. Urol. 2014;2(2):145-148
- Lander EB. Lee I. Giant Scrotal Lipomatosis. J. Urol. 156: 1773, 1996.
- Lander EB. Severe Hemoglobinuria Masquerading as gross hematuria following mitral valve replacement. J. Urol. 153: 1639, 1995.
- Lander EB, Shanberg AM, Tansey LA, Sawyer DE, Groncy PK, Finkelstein JZ. The use of continent diversion in the Management of rhabdomyosarcoma of the Prostate in childhood J. Urol. 147: 1602, 1992.
- Lander EB, Hewitt CW, Black KS Martin DC. Evaluation of rat Renal Allograft Model in comparison to man: A physiological perspective. J. Urol. 136:710, 1986.
- Vyden JK, Nagasawa K, Kanazawa M, Rose, Seino Y, Robertson M, Lander EB. Lack of effect of Cyclandelate in Peripheral Arterial disease. Angiology 35:1, 1984.
- Detection of Unsuspected cognitive impairment in Cardiac rehabilitation patients. Chapter 24 in “Post Myocardial Infraction Management and Rehabilitation.’’ M. Dekker, Inc, 1983.
- Study of Salivary and Serum Antibody Response in Mice following oral challenge with S. Mutans. Winning paper at statewide NASA youth Science Congress, 1978.
Glycosaminoglycan encapsulation in a liposomal nanocarrier drug delivery system. Patent application No. 13/802,445 filed Mar 13, 2013 entitled: Method and Composition for Treating Cystitis.
Growth factor and stem cell encapsulation in a liposomal nanocarrier drug delivery system. Patent application No. 13/900,518 filed May 22, 2013 entitled: Method and Composition for Treating Cystitis.
Combination of Shock Wave and Stem Cell for Degenerative Disease. Provisional patent filed 2014.
Transurethral Prostatectomy: Reduced Duration of Catheterization and Hospitalization presented at the 67th Annual Meeting Western Section American Urological Association. Vancouver B.C. Canada on August 1st, 1991.
Fat Derived Stem Cells presented at 7th Annual National Society of Cosmetic Surgeons. Las Vegas, Nevada, 2012.
Interstitial Cystitis: Current Concepts presented at Grand Rounds event Annenberg Center for Health Sciences at Eisenhower Medical Center, Rancho Mirage, California on January 3, 2013.
Adipose Derived Stem Cells and Urologic Regenerative Medicine presented at American Academy of Cosmetic Surgery 29th Annual Scientific Meeting. Las Vegas, Nevada on January 16th,2013.
New Horizons In Regenerative Urology presented at SELECTBIO Clinical Translation of Stem Cells Summit 2013. Rancho Mirage, California on January 23rd, 2013.
Autologous Adipose Derived Stromal Vascular Fraction for the Treatment of Interstitial cystitis‐ A Pilot Study presented at American Urologic Association Western Section 89th Annual Meeting. Monterey, California on November 3rd, 2013.
Intravesical Pentosan Polysulfate Encapsulated in a Liposome Nanocarrier for Interstitial Cystitis. Poster presented at American Urologic Association Western Section 89th Annual Meeting. Monterey, California on November 3rd, 2013.
Autologous Adipose Derived Stromal Vascular Fraction Combined with Low Intensity Shock Wave Therapy for the Treatment of Peyronies Disease‐ A Pilot Study. Poster presented at American Urologic Association Western Section 89th Annual Meeting. Monterey, California on November3rd, 2013.
Regenerative Urology presented at 2013 World Stem Cell Summit, San Diego, California, on December 4th, 2013.
Stromal Vascular Fraction Combined with Low Intensity Shock Wave Therapy for Peyronies Disease presented at 2014 American Academy of Cosmetic Surgery 30th Annual Scientific Meeting. Hollywood, Florida, on January 14th, 2014.
Regenerative Urology presented at FATS Bangkok 2014. Visiting Surgeon at Ramathibodi Hospital in Bangkok, Thailand on April 18th, 2014.
Regenerative Urology and ED presented at SELECTBIO Clinical Translation of Stem Cells Summit 2014. Rancho Mirage, California on April 21st, 2014.
The Role of The Surgeon in Regenerative Urology at Anti-Aging Regenerative & Aesthetic Medicine 22nd Annual World Congress. Orlando, Florida on May 17th, 2014.
The Role of The Physician In Regenerative Urology presented at 2014 John C. Lincoln Health Network Medical Staff Retreat. Sedona, Arizona on June 9th, 2014.
Innovations In Stem cell Treatments and Regenerative Medicine presented at 2014-2015 World Medical tourism and global Healthcare Congress. Washington DC on September 21st, 2014.
Adipose Derived Stem Cells And Extracorporeal Shock Wave Therapy For Erectile Dysfunction. Poster presented at American Urologic Association Western Section 90th Annual Meeting. Mauai, Hawaii on October 26th, 2014.
Peyronies Disease. Presented at the American Academy of Cosmetic Surgery’s 31st Annual Scientific Meeting-Technological Advancements in Cosmetic Surgery. New Orleans, Louisiana on January 14th, 2015.
Treatment of Peyronie’s Disease with Autologous Adipose Derived Stromal Vascular Fraction Rich in Adult Stem Cells Combined with Penile Shock Wave Therapy. Sexual Medicine Podium Session American Urologic Association Western Section 91st Annual Meeting. Indian wells, California on October 27th, 2015.
Treatment of Interstitial Cystitis With Autologous Adipose Derived Stromal Vascular Fraction Rich in Adult Stem Cells and Growth Factors. Pelvic Floor Podium Session American Urologic Association Western Section 91st Annual Meeting. Indian wells, California on October 27th, 2015.
Session chairman and speaker: Various Disease Classes Addressed by Adult Stem Cells—Therapies in Development and in the Clinical/Surgical Realm. Clinical and Surgical Translation of adult Stem Cells. San Diego, California on Nov 9th and 10th, 2015.
Session Moderator and Presenter: Stromal Vascular Fraction and Urology. Academy of Regenerative Practices, Fort Lauderdale, Florida on February 6th, 2016.
Stromal Vascular Fraction and Pain. Florida Society of Interventional Pain Physicians 2016 Annual Meeting. Orlando, Florida on May 21st, 2016.
SVF Anatomy, Physiology, MOA, and Preparation. Regenerative Medicine Review Course. American Society of Interventional Pain Physicians. Las Vegas, Nevada on August 19th, 2016.
SVF Applications in Chronic pain and Other Disorders. Regenerative Medicine Review Course. American Society of Interventional Pain Physicians. Las Vegas, Nevada on August 19th, 2016.
Injection of Autologous Mesenchymal SVF into the Human Brain Ventricular System for Neurodegenerative Disorders: 2-Year Results of a Phase 1 study in 20 Patients. Presented by Dr. Chris Duma (lead author) at the Congress of Neurological Surgeons CNS Annual meeting in San Diego, California on September 24th, 2016 and at Podium session of International Society for Cell Therapy ISCT North America Regional Meeting in Memphis Tennessee on Sept 30th, 2016.
Stromal Vascular Fraction Cells: Evolution, Physiology, Indications, mechanism of Action and Preparation. Essentials of Regenerative Medicine in Interventional Pain Management. Faculty Instructor for American Society of Interventional Pain Physicians. Memphis, Tennessee on March 3rd and 4th, 2017.
New applications of Stem Cells in clinical Practice. Sixth Annual EMA Primary Care Medical Education Conference “Innovations in Healthcare.” Eisenhower Medical Center, Rancho Mirage, California on May19th, 2017
Stromal Vascular Fraction Cells: Evolution, Physiology, Indications, mechanism of Action and Preparation with Cadaver Training Course. Essentials of Regenerative Medicine in Interventional Pain Management. Faculty Instructor for American Society of Interventional Pain Physicians. Orlando, Florida on June 16th and 17th, 2017.